Strategies to Re-Sensitize Castration-Resistant Prostate Cancer to Antiandrogen Therapy

Since prostate cancer (PCa) was described as androgen-dependent, the androgen receptor (AR) has become the mainstay of its systemic treatment: androgen deprivation therapy (ADT). Although, through recent years, more potent drugs have been incorporated, this chronic AR signaling inhibition inevitably...

Descripción completa

Detalles Bibliográficos
Autores principales: Congregado Ruiz, Belén, Rivero Belenchón, Inés, Lendínez Cano, Guillermo, Medina López, Rafael Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135790/
https://www.ncbi.nlm.nih.gov/pubmed/37189723
http://dx.doi.org/10.3390/biomedicines11041105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135790/
https://www.ncbi.nlm.nih.gov/pubmed/37189723
http://dx.doi.org/10.3390/biomedicines11041105

Ejemplares similares